Blistex to launch two new lip products
OAK BROOK, Ill. — Blistex is expanding its lip care portfolio with the October launch of two new products: Blistex Revive & Restore and Blistex Cold & Allergy Lip Soother.
Blistex Revive & Restore: Two formulas, Revive and Restore, come in separate nesting jars that lock together. The Revive formula protects lips, while the Restore formula makes them soft, healthy and radiant. Whether carried alone or as a set, Revive & Restore delivers a customized, unique two-jar rejuvenation approach. It retails for $1.99 to $3.29 (for the two-jar pack).
Blistex Cold & Allergy Lip Soother: Formulated with soothing ingredients and an advanced analgesic, this formula is designed to alleviate lip discomfort and bring relief to those experiencing allergies, a cold or the flu. The product boasts Pramoxine HCL, dimethicone, glycerin, and vitamins C and E. It retails for between $1.89 and $2.69.
Ulta celebrates fall with ’21 Days of Beauty’ event
CHICAGO — Beauty retailer Ulta kicked off on Sept. 4 its “21 Days of Beauty” at stores nationwide, a celebration focusing on fall’s trends and corresponding free gifts, season beauty tips, in-store consultations and live demos from beauty brand experts.
Each day throughout “21 Days of Beauty,” the retailer will feature one "Beauty Steal" and a "Beauty Focus Day." Beauty Steals include special pricing and buy-one-get-one-free" offers. Beauty Focus Days offer makeup and skin care specialists who focus on selected brands each day, providing individual makeup tips, trend updates and skin consultations.
Participants include such cosmetic and skin care brands as Bare Escentuals, Philosophy, Smashbox, Too Faced, Bliss, Urban Decay, Murad, Kinerase, Purminerals and Stila.
Helping to celebrate the event, Ulta has teamed up with Allure and Glamour to offer a yearly subscription to both magazines for $21.
Tracking medication adherence easier in integrated health systems with EHRs, Kaiser Permanente study finds
DENVER — Patients using an integrated healthcare system that uses its own pharmacy and electronic health records get their medications filled at a higher rate than those in nonintegrated systems, according to a new study published in the Journal of General Internal Medicine.
The study — conducted by Kaiser Permanente Colorado among 12,061 patients with newly ordered medications for diabetes, blood pressure and cholesterol — found that 93% of patients got their prescriptions for blood pressure drugs filled, along with 89% of those taking diabetes medications and 87% of those taking cholesterol drugs.
Previous studies in nonintegrated health systems found that rates of failure to fill new prescriptions — known as primary nonadherence — were as high as 22%, but the percentage was likely overestimated because those systems must link medication orders and pharmacy claims from different organizations, and pharmacy claims databases don’t include patients who don’t fill their first prescriptions or those who pay cash, researchers said. By contrast, an integrated health system keeps track of data on who fills a prescription and who doesn’t.
"Given that adherence to medications is directly associated with improved clinical outcomes, higher quality of life and lower healthcare costs across many chronic conditions, it is important to examine why some people never start the medications their doctors prescribe," said Marsha Raebel, an investigator in pharmacotherapy with the Kaiser Permanente Colorado Institute for Health Research and the University of Colorado School of Pharmacy. "Having electronic health record medication order entry linked to pharmacy dispensing information makes it easier for clinicians and researchers to identify patients who are not getting their new prescriptions filled."